Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody. 2006

Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
Biofisika Unitatea (CSIC-UPV/EHU) and Biokimika Saila, Euskal Herriko Unibertsitatea, Posta Kutxa 644, 48080 Bilbao, Spain.

HIV-1 neutralizing monoclonal antibody (Mab) 2F5 recognizes a membrane-partitioning gp41 sequence. Just recently its capacity to react with cardiolipin has been demonstrated. Here, we have studied the specificity of Mab2F5-phospholipid interactions comparing partitioning into lipid bilayers with recognition of molecular species dispersed in solution. Using a liposome-based ELISA we demonstrate a preferential association with cardiolipin bilayers. When different soluble lysoderivatives were compared in their capacity to inhibit Mab2F5 binding to immobilized HIV-1 peptide epitope, only dilysocardiolipin resulted effective in blocking the process. Dilyso-cardiolipin also competed with native-functional gp41 for 2F5 recognition. Thus, our data support specific cardiolipin recognition by 2F5 that is not dependent on lipid bilayer assembly and involves the epitope-binding site. These findings might be of relevance for understanding the molecular basis of HIV-1 immune evasion.

UI MeSH Term Description Entries
D008051 Lipid Bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Bilayers, Lipid,Bilayer, Lipid,Lipid Bilayer
D008561 Membrane Fusion The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. Fusion, Membrane,Fusions, Membrane,Membrane Fusions
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002308 Cardiolipins Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS. Cardiolipin,Diphosphatidylglycerol,Diphosphatidylglycerols
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001666 Binding Sites, Antibody Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS. Antibody Binding Sites,Paratopes,Antibody Binding Site,Binding Site, Antibody,Paratope

Related Publications

Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
January 2003, Molekuliarnaia biologiia,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
November 2001, Journal of virology,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
April 1994, Proceedings of the National Academy of Sciences of the United States of America,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
December 1994, AIDS research and human retroviruses,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
October 2004, Journal of virology,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
January 2017, Frontiers in immunology,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
September 2008, Journal of virology,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
April 2009, Journal of virology,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
November 2009, Journal of virology,
Silvia Sánchez-Martínez, and Maier Lorizate, and Katinger Hermann, and Renate Kunert, and Gorka Basañez, and José L Nieva
April 2004, Journal of molecular biology,
Copied contents to your clipboard!